Michael Ruzicka, Simone Sachenbacher, Fides Heimkes, Aline Olivia Uebleis, Susanne Karch, Fabienne Grosse-Wentrup, Gerardo Jesus Ibarra Fonseca, Nora Wunderlich, Johannes Bogner, Julia Mayerle, Michael von Bergwelt-Baildon, Peter Falkai, Marion Subklewe, Thomas Ruzicka, Christopher Benesch, Elisabeth Valdinoci, Anna Pernpruner, Anabel Thomas, Bernhard Heindl, Hans Christian Stubbe, Kristina Adorjan
Cognitive symptoms (CS) belong to the most common manifestations of the Post COVID-19 (PC) condition. We sought to objectify CS in PC patients using routine diagnostic assessments: neurocognitive testing (NCT) and brain imaging (BI). Further, we investigated possible associations of CS with patient reported outcomes (PROs), and risk factors for developing CS. Clinical data and PROs of 315 PC patients were assessed at a mean of 6 months after SARS-CoV-2 infection. 231 (73.3%) patients reported any sort of CS...
May 13, 2024: European Archives of Psychiatry and Clinical Neuroscience